Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
25.86
+0.20 (0.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immunovant Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
| Net Income | -323.01 | -259.34 | -210.96 | -156.73 | -107.43 | -66.39 | Upgrade
|
| Depreciation & Amortization | 0.29 | 0.23 | 0.19 | 0.13 | 0.07 | 0.02 | Upgrade
|
| Other Amortization | - | - | - | - | - | 1.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.01 | Upgrade
|
| Stock-Based Compensation | 46.05 | 41.12 | 32.3 | 34.24 | 18.82 | 6.96 | Upgrade
|
| Other Operating Activities | 0.64 | 1.13 | 1.13 | 1.11 | 0.65 | -0.4 | Upgrade
|
| Change in Accounts Receivable | -0.53 | -4.58 | 11.76 | -11.63 | -0.6 | - | Upgrade
|
| Change in Accounts Payable | 12.94 | 5.78 | -17.12 | 16.25 | 1.25 | 0.97 | Upgrade
|
| Change in Income Taxes | 0.02 | 0.02 | 0.46 | -0.09 | -0.51 | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -8.04 | 1.41 | -5.95 | 10.61 | 4.42 | 3.83 | Upgrade
|
| Operating Cash Flow | -271.64 | -214.23 | -188.19 | -106.11 | -83.33 | -53.36 | Upgrade
|
| Capital Expenditures | -0.66 | -0.36 | -0.2 | -0.25 | -0.21 | -0.03 | Upgrade
|
| Investing Cash Flow | -0.66 | -0.36 | -0.2 | -0.25 | -0.21 | -0.03 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 42.91 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 42.91 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -3.19 | -5 | Upgrade
|
| Total Debt Repaid | - | - | - | - | -3.19 | -5 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -3.19 | 37.91 | Upgrade
|
| Issuance of Common Stock | 478.82 | 478.44 | 71.16 | 200.13 | 387.54 | 1.16 | Upgrade
|
| Other Financing Activities | -6.01 | -6.01 | -0.27 | - | -1.24 | 107.91 | Upgrade
|
| Financing Cash Flow | 472.81 | 472.43 | 70.89 | 200.13 | 383.11 | 146.97 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.51 | 0.99 | 0.22 | -0.09 | - | - | Upgrade
|
| Net Cash Flow | 203.01 | 258.83 | -117.29 | 93.67 | 299.58 | 93.59 | Upgrade
|
| Free Cash Flow | -272.3 | -214.59 | -188.39 | -106.37 | -83.54 | -53.39 | Upgrade
|
| Free Cash Flow Per Share | -1.87 | -1.55 | -1.53 | -0.97 | -0.95 | -1.24 | Upgrade
|
| Cash Income Tax Paid | 0.81 | 0.51 | - | - | 0.17 | 0.06 | Upgrade
|
| Levered Free Cash Flow | -160.83 | -124.15 | -107.82 | -47.88 | -43.79 | -28.94 | Upgrade
|
| Unlevered Free Cash Flow | -160.83 | -124.15 | -107.82 | -47.88 | -43.79 | -28.55 | Upgrade
|
| Change in Net Working Capital | -13.78 | -3.74 | 9.94 | -15.53 | -5.11 | -2.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.